GreatBanc Trust’s AbbVie ABBV Stock Holding History

GreatBanc Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$409K	Sell	1,625 -31	-2%	-$6.67K	0.25%	41
2026 Q1	$360K	Sell	1,656 -4	-0.2%	-$887	0.25%	45
2025 Q4	$379K	Buy	1,660 +30	+2%	+$6.83K	0.27%	45
2025 Q3	$377K	Buy	+1,630	New	+$332K	0.26%	47

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GreatBanc Trust's ABBV Position: Q2 2026 in Review

GreatBanc Trust reduced its AbbVie (ABBV) stake by 1.9% in Q2 2026, selling an estimated $6.67K and leaving 1,625 shares worth $409K. The position accounts for 0.25% of the portfolio, ranked #41.

GreatBanc Trust first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

GreatBanc Trust held 1,625 shares of AbbVie worth $409K as of Q2 2026.
GreatBanc Trust sold 31 AbbVie shares in Q2 2026, an estimated $6.67K.
AbbVie made up 0.25% of GreatBanc Trust's portfolio in Q2 2026, its #41 holding.
GreatBanc Trust first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on GreatBanc Trust's 13F filing for Q2 2026, filed 30 Jul 2026.